Back to Treatments

Treatment

Lomustine

1
Conditions
40
Trials
5,000
Participants
25%
Average Safety

Condition Evidence

Brain and central nervous system cancer

40 trials · 5,000 participants

45% effectiveness · 25% safety
Lomustine | DFDA